A Short Hairpin DNA Analogous to miR-125b Inhibits C-Raf Expression, Proliferation, and Survival of Breast Cancer Cells

被引:43
作者
Hofmann, Marco H. [1 ]
Heinrich, Jochen [1 ]
Radziwil, Gerald [1 ]
Moelling, Karin [1 ,2 ]
机构
[1] Univ Zurich, CH-8006 Zurich, Switzerland
[2] Inst Adv Study, Berlin, Germany
关键词
CAENORHABDITIS-ELEGANS; MESSENGER-RNA; GENE-THERAPY; CYCLIN D1; IN-VIVO; MICRORNAS; ANTISENSE; ERK; HIV; OLIGODEOXYNUCLEOTIDE;
D O I
10.1158/1541-7786.MCR-09-0043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The noncoding RNA miR-125b has been described to reduce ErbB2 protein expression as well as proliferation and migration of cancer cell lines. As additional target of miR-125b, we identified the c-raf-1 mRNA by sequence analysis. We designed a short hairpin-looped oligodeoxynucleotide (CIDN) targeted to the same 3' untranslated region of c-raf-1 mRNA as miR-125b. The fully complementary ODN antisense strand is linked to a second strand constituting a partially double-stranded structure of the CIDN. Transfection of the c-raf-1-specific ODN (ODN-Raf) in a breast cancer cell line reduced the protein levels of C-Raf, ErbB2, and their downstream effector cyclin D1 similar to miR-125b. MiR-125b as well as ODN-Raf showed no effect on the c-raf-1 mRNA level in contrast to small interfering RNA. Unlike miR-125b, ODN-Raf induced a cytopathic effect. This may be explained by the structural properties of ODN-Raf, which can form G-tetrads. Thus, the short hairpin-looped ODN-Raf, targeting the same region of c-raf-1 as miR-125b, is a multifunctional molecule reducing the expression of oncoproteins and stimulating cell death. Both features may be useful to interfere with tumor growth. (Mol Cancer Res 2009;7(10):1635-44)
引用
收藏
页码:1635 / 1644
页数:10
相关论文
共 62 条
[1]   RNAi therapeutics: Principles, prospects and challenges [J].
Aagaard, Lars ;
Rossi, John J. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (2-3) :75-86
[2]   CYCLIN D1 IS A NUCLEAR-PROTEIN REQUIRED FOR CELL-CYCLE PROGRESSION IN G(1) [J].
BALDIN, V ;
LUKAS, J ;
MARCOTE, MJ ;
PAGANO, M ;
DRAETTA, G .
GENES & DEVELOPMENT, 1993, 7 (05) :812-821
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   Everything you wanted to know about small RNA but were afraid to ask [J].
Boyd, Scott D. .
LABORATORY INVESTIGATION, 2008, 88 (06) :569-578
[5]   Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy [J].
Cepeda, Victoria ;
Fuertes, Miguel A. ;
Castilla, Josefina ;
Alonso, Carlos ;
Quevedo, Celia ;
Soto, Manual ;
Perez, Jose M. .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2006, 1 (01) :39-53
[6]   Raf-1 promotes cell survival by antagonizing apoptosis signal-regulating kinase 1 through a MEK-ERK independent mechanism [J].
Chen, J ;
Fuji, K ;
Zhang, LX ;
Roberts, T ;
Fu, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (14) :7783-7788
[7]   SELECTIVE ANTI-GENE THERAPY FOR CANCER - PRINCIPLES AND PROSPECTS [J].
COHEN, JS .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 168 (02) :351-359
[8]   Structure of a d(TGGGGT) quadruplex crystallized in the presence of Li+ ions [J].
Creze, Christophe ;
Rinaldi, Bruno ;
Haser, Richard ;
Bouvet, Philippe ;
Gouet, Patrice .
ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 2007, 63 :682-688
[9]   SELECTIVE ELIMINATION OF MESSENGER-RNAS INVIVO - COMPLEMENTARY OLIGODEOXYNUCLEOTIDES PROMOTE RNA DEGRADATION BY AN RNASE H-LIKE ACTIVITY [J].
DASH, P ;
LOTAN, I ;
KNAPP, M ;
KANDEL, ER ;
GOELET, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (22) :7896-7900
[10]   Functional genomics and target validation approaches using antisense oligonucleotide technology [J].
Dean, NM .
CURRENT OPINION IN BIOTECHNOLOGY, 2001, 12 (06) :622-625